1007252-25-6Relevant articles and documents
Structure-activity relationships of novel iron chelators for the treatment of iron overload disease: The methyl pyrazinylketone isonicotinoyl hydrazone series
Kalinowski, Danuta S.,Sharpe, Philip C.,Bernhardt, Paul V.,Richardson, Des R.
, p. 331 - 344 (2008/09/18)
The design of novel Fe chelators with high Fe mobilization efficacy and low toxicity remains an important priority for the treatment of Fe overload disease. We have designed and synthesized the novel methyl pyrazinylketone isonicotinoyl hydrazone (HMPIH)